Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
AI Chat Bot for Websites
sajith.xp.pk
Updated:
Thursday at 1:17 PM
Puffin Rock Characters Plush Toy Set
anil1961
Updated:
Nov 7, 2026
Toyota Vitz scp10 For Sale
Lakmal Bandara
Updated:
Nov 4, 2026
Kandy
Welcome all my all new pet shop Bark.lk
dilumrane
Updated:
Nov 2, 2026
Windows RDP Only Rs.500 a month
Blogerwiki
Updated:
Nov 1, 2026
Electronics
Vehicles
Property
Search
Reply to thread
Forums
ElaKiri.com
News and Updates
Harvard Scientists discover how Cancer cells turn off the Immune System.
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="imhotep" data-source="post: 28216154" data-attributes="member: 562115"><p>A team led by researchers at Harvard Medical School has identified a way that tumor cells can turn off the immune system, allowing the tumor to grow unchecked.</p><p>Tumor cells with a particular mutation release a chemical, a metabolite, that weakens nearby immune cells, rendering them less capable of killing cancer cells. They found that the metabolite secreted by the tumor hijacks the body's normal defense mechanism and causes it to break down,</p><p></p><p>"Our study highlights an immune component in this type of cancer that wasn't fully appreciated before. We now know that a metabolite produced by tumor cells can impact nearby immune cells to make the surrounding environment less hostile for the cancer."</p><p></p><p>Marcia Haigis, Senior Author, Professor of Cell Biology, Blavatnik Institute at HMS-</p><p></p><p>The team worked on tumors with a mutation in a gene called isocitrate dehydrogenase, or <em>IDH</em>. <strong>IDH </strong>mutations occur in around 3.5 percent of cancers, including solid cancers such as gliomas and blood cancers such as acute myeloid leukemia. In fact, approximately 80 percent of low-grade gliomas and secondary glioblastomas have an <em>IDH</em> mutation. Tumor cells that harbor this mutation secrete D-2-hydroxyglutarate (D-2HG), a metabolite not normally found at high levels in the human body.</p><p>The therapeutic implication of this research is still unknown and further research is needed to develop therapies that take advantage of the interaction between cancer cells and immune cells.</p></blockquote><p></p>
[QUOTE="imhotep, post: 28216154, member: 562115"] A team led by researchers at Harvard Medical School has identified a way that tumor cells can turn off the immune system, allowing the tumor to grow unchecked. Tumor cells with a particular mutation release a chemical, a metabolite, that weakens nearby immune cells, rendering them less capable of killing cancer cells. They found that the metabolite secreted by the tumor hijacks the body's normal defense mechanism and causes it to break down, "Our study highlights an immune component in this type of cancer that wasn't fully appreciated before. We now know that a metabolite produced by tumor cells can impact nearby immune cells to make the surrounding environment less hostile for the cancer." Marcia Haigis, Senior Author, Professor of Cell Biology, Blavatnik Institute at HMS- The team worked on tumors with a mutation in a gene called isocitrate dehydrogenase, or [I]IDH[/I]. [B]IDH [/B]mutations occur in around 3.5 percent of cancers, including solid cancers such as gliomas and blood cancers such as acute myeloid leukemia. In fact, approximately 80 percent of low-grade gliomas and secondary glioblastomas have an [I]IDH[/I] mutation. Tumor cells that harbor this mutation secrete D-2-hydroxyglutarate (D-2HG), a metabolite not normally found at high levels in the human body. The therapeutic implication of this research is still unknown and further research is needed to develop therapies that take advantage of the interaction between cancer cells and immune cells. [/QUOTE]
Insert quotes…
Verification
Haya warak paha keeyada? (haya wadi kireema paha)
Post reply
Top
Bottom